Antinociceptive effects of gabapentin & its mechanism of action in experimental animal studies

Indian Journal of Medical Research

Volumn 135, Issue 5, 2012, Pages 630-635

  Kilic, Fatma Sultan ^a   Sirmagul, Basar ^a   Yildirim, Engin ^a   Oner, Setenay ^a   Erol, Kevser ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Antinociceptive effect; Gabapentin; Mice; nNOS; PGE2; Rat hippocampus slices

Indexed keywords

ARACHIDONIC ACID; CYPROHEPTADINE; GABAPENTIN; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NALOXONE; NEURONAL NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2;

ADAPTATION; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; IN VITRO STUDY; MALE; MOUSE; NITRERGIC NERVE; NONHUMAN; SEROTONINERGIC SYSTEM; TAIL FLICK TEST; WRITHING TEST;

AMINES; ANALGESICS; ANIMALS; CYCLOHEXANECARBOXYLIC ACIDS; DINOPROSTONE; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; HUMANS; MALE; MICE; NITRIC OXIDE SYNTHASE TYPE I; PAIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84863228514     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Dixit RK, Bhargava VK. Cholinergic mechanism in gabapentin analgesia. Indian J Pharmacol 2001; 33: 221-2.
2. Bensson JM. The neurobiology of pain. Lancet 1999; 353: 1610-5.
3. Magnus L. Non epileptic uses of gabapentin. Epilepsia 1999; 40: 66-74.
4. Lu Y, Westlund KN. Gabapentin attenuates nociceptive behaviors in an acute arthritis model in rats. J Pharmacol Exp Therp 1999; 290: 214-9.
5. Moretti R, Antonello RM, Torre P, Cazzato G. Headache and neck pain: Gabapentin as a posible treatment. J Headache Pain 2000; 1: 155-61.
6. Shimoyama M, Shimoyama N, Inturrisi CE, Elliott KJ. Gabapentin enhances the antinociceptive effects of spinal morphine in the rat tail-flick test. Pain 1997; 72: 375-82.
7. Yoon MH, Choi J. Hemodynamic effects of gabapentin in rats. J Korean Med Sci 2003; 18: 478-82.
8. Bertrand S, Ng GY, Purisai MG, Wolfe SE, Severidt MW, Nouel D, et al. The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain gamma-aminobutyric acid type B receptors negatively coupled to voltage-dependent calcium channels. J Pharmacol Exp Ther 2001; 298: 15-24.
9. Eddy NB, Leinbach D. Synthetic analgesics(II): Dithienylbutenyl and Dithienylbutylamines. J Pharmacol Exp Ther 1953; 107: 385-93.
10. Bianchi, C, Franceshini J. Experimental observations of Haffner's method for testing analgesic drugs. Br J Pharmacol 1954; 9: 280-4.
11. D'Amour, FE, Smith DL. A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941; 72: 74-9.
12. Turan-Zitouni G, Sivaci M, Kilic FS, Erol K. Synthesis of some triazolyl-antipyrine derivatives and investigation of analgesic activity. Eur J Med Chem 2001; 36: 685-9.
13. Koster R, Anderson M, De Beer EJ. Acetic acid for analgesic screening. Fed Proc 1959; 18: 412-8.
14. Kilic FS, Dogan AE, Baydemir C, Erol K. The acute effects of mirtazepine on pain related behavior in healthy animals. Neurosciences 2011; 16: 217-23.
15. Goldlust A, Su TZ, Wlty D, Taylor CP, Oxander D. Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA. Epilepsy Res 1995; 22: 1-11.
16. Yoon MH, Choi J, Jeong SW. Spinal gabapentin and antinociception: Mechanism of action. J Korean Med Sci 2003; 18: 255-61.
17. Luo ZD, Calcutt NA, Higuera ES, Valder CR, Song YH, Svensson CI, et al. Injury type specific calcium channel alpha 2-delta 1 subunit upregulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 2002; 303: 1199-205.
18. Schmauss C, Yaksh T. In vivo studies an spinal opiate receptor systems mediating antinociception II. Pharmacological profiles suggesting a differantial association of mu, delta and kappa receptors with visseral chemical and cutaneous thermal stimuli in the rat. J Pharmacol Exp Ther 1984; 228: 1-12.
19. Hansen J, Gilron I, Hong M. The effects of intratechal gabapentin on spinal morphin tolerance in the rat tail flick and paw pressure tests. Anesth Analg 2004; 99: 1180-4.
20. Bardin L, Lavarenne J, Eschalier A. Serotonin receptor subtype involve in the spinal antinociceptive effects of 5-HT in rats. Pain 2000; 86: 11-8.
21. Dixit RK, Bhargava VK. Neurotransmitter mechanisms in gabapentin antinociception. Pharmacology 2002; 65: 198-203.
22. Rettori V, Gimeno M, Lyson K, McCann SM. Nitric oxide mediates norepineprine-induced PGE2 release from the hypothalamus. Proc Natl Acad Sci USA 1992; 89: 11543-6.
23. Elfline GS, Branda EM, Babich M, Quock RM. Antagonism by NOS inhibition of the behavioral effects of benzodiazepine and GABA A receptor agonist in the mouse elevated plusmaze. Neuropsychopharmacology 2004; 29: 1419-25.
24. Taylor CP. Mechanism of action of gabapentin. Rev Neurol 1997; 153 (Suppl 1): S39-45.
25. Wall MJ. Endogenous nitric oxide modulates GABA ergic transmission to granule cells in adult rat cerebellum. Eur J Neurosci 2003; 18: 869-78.
26. Sharma HS. Neurobiology of the nitric oxide in nervous system. Basic and clinical perspectives. Amino Acids 1998; 14: 83-5.
27. DiGirolamo G, Farina M, Riberio ML, Ogando D, Aisemberg J, de los Santos AR, et al. Effects of cyclooxygenase inhibitor pretreatment on nitric oxide production, nNOS and iNOS expression in rat cerebellum. Br J Pharm 2003; 139: 1164-70.
28. Minami T, Nishihara I, Ito S, Sakamoto K, Hyodo M, Hayaishi O. Nitric oxide mediates allodynia induced by intrathecal administration of prostaglandin E2 or prostoglandin F2 alpha in coscious mice. Pain 1995; 61: 285-90.
29. Siegal T, Siegal T. Serotonergic manipulations in experimental neoplastic spinal cord compression. J Neurosurg 1993; 78: 929-37.